Ancom Nylex Berhad Valuation

Is ANCOMNY undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ANCOMNY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ANCOMNY (MYR0.99) is trading below our estimate of fair value (MYR1.02)

Significantly Below Fair Value: ANCOMNY is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ANCOMNY?

Key metric: As ANCOMNY is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ANCOMNY. This is calculated by dividing ANCOMNY's market cap by their current earnings.
What is ANCOMNY's PE Ratio?
PE Ratio15.3x
EarningsRM 73.88m
Market CapRM 1.13b

Price to Earnings Ratio vs Peers

How does ANCOMNY's PE Ratio compare to its peers?

The above table shows the PE ratio for ANCOMNY vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average23.3x
HEXZA Hexza Corporation Berhad
26.5xn/aRM 191.4m
SENFONG Seng Fong Holdings Berhad
11.4x10.2%RM 718.0m
BAHVEST Bahvest Resources Berhad
45.1xn/aRM 1.5b
JTIASA Jaya Tiasa Holdings Berhad
10x11.7%RM 1.3b
ANCOMNY Ancom Nylex Berhad
15.3x17.7%RM 1.1b

Price-To-Earnings vs Peers: ANCOMNY is good value based on its Price-To-Earnings Ratio (15.3x) compared to the peer average (23.3x).


Price to Earnings Ratio vs Industry

How does ANCOMNY's PE Ratio compare vs other companies in the MY Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
ANCOMNY 15.3xIndustry Avg. 17.6xNo. of Companies5PE01020304050+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ANCOMNY is good value based on its Price-To-Earnings Ratio (15.3x) compared to the MY Chemicals industry average (17.6x).


Price to Earnings Ratio vs Fair Ratio

What is ANCOMNY's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ANCOMNY PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio15.3x
Fair PE Ratio15.2x

Price-To-Earnings vs Fair Ratio: ANCOMNY is expensive based on its Price-To-Earnings Ratio (15.3x) compared to the estimated Fair Price-To-Earnings Ratio (15.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ANCOMNY forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 0.99
RM 1.34
+35.4%
10.7%RM 1.50RM 1.16n/a4
Dec ’25RM 1.02
RM 1.34
+31.4%
10.7%RM 1.50RM 1.16n/a4
Nov ’25RM 1.04
RM 1.34
+28.8%
10.7%RM 1.50RM 1.16n/a4
Oct ’25RM 1.02
RM 1.39
+36.0%
7.0%RM 1.50RM 1.26n/a4
Sep ’25RM 0.99
RM 1.47
+48.2%
1.6%RM 1.50RM 1.44n/a4
Aug ’25RM 1.06
RM 1.47
+38.4%
1.6%RM 1.50RM 1.44n/a4
Jul ’25RM 1.10
RM 1.43
+29.5%
6.0%RM 1.50RM 1.28n/a4
Jun ’25RM 1.03
RM 1.42
+37.5%
6.9%RM 1.50RM 1.28n/a3
May ’25RM 1.03
RM 1.42
+37.5%
6.9%RM 1.50RM 1.28n/a3
Apr ’25RM 1.01
RM 1.53
+51.5%
5.8%RM 1.65RM 1.44n/a3
Mar ’25RM 1.06
RM 1.53
+44.3%
5.8%RM 1.65RM 1.44n/a3
Feb ’25RM 1.09
RM 1.53
+40.4%
5.8%RM 1.65RM 1.44n/a3
Jan ’25RM 1.13
RM 1.53
+35.4%
5.8%RM 1.65RM 1.44n/a3
Dec ’24RM 1.15
RM 1.53
+33.0%
5.8%RM 1.65RM 1.44RM 1.023
Nov ’24RM 1.18
RM 1.53
+29.7%
5.8%RM 1.65RM 1.44RM 1.043
Oct ’24RM 1.23
RM 1.59
+29.0%
9.8%RM 1.80RM 1.43RM 1.023
Sep ’24RM 1.06
RM 1.59
+49.7%
9.8%RM 1.80RM 1.43RM 0.993
Aug ’24RM 1.02
RM 1.59
+55.6%
9.8%RM 1.80RM 1.43RM 1.063
Jul ’24RM 0.95
RM 1.54
+61.8%
15.9%RM 1.80RM 1.19RM 1.104
Jun ’24RM 0.97
RM 1.54
+58.5%
15.9%RM 1.80RM 1.19RM 1.034
May ’24RM 1.06
RM 1.54
+45.0%
15.9%RM 1.80RM 1.19RM 1.034
Apr ’24RM 1.08
RM 1.54
+42.4%
15.9%RM 1.80RM 1.19RM 1.014
Mar ’24RM 1.16
RM 1.54
+32.5%
15.9%RM 1.80RM 1.19RM 1.064
Feb ’24RM 1.20
RM 1.46
+21.3%
16.1%RM 1.80RM 1.19RM 1.094
Jan ’24RM 1.03
RM 1.34
+30.1%
10.6%RM 1.53RM 1.19RM 1.133
Dec ’23RM 0.96
RM 1.42
+46.6%
8.1%RM 1.53RM 1.30RM 1.152

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies